| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 78, 1282-1286, Copyright © 1994 by Endocrine Society
ARTICLES |
AL Ogilvy-Stuart, PE Clayton and SM Shalet
Department of Endocrinology, Christie Hospital, Manchester, United Kingdom.
Low doses of cranial irradiation (18-24 gray) employed in the management of acute lymphoblastic leukemia may cause early or precocious puberty, predominantly in girls. To determine whether this sexual dichotomy exists at higher irradiation doses (25-47 gray), the onset of puberty was identified in 46 GH-deficient children (30 males) previously irradiated for a brain tumor not involving the hypothalamic- pituitary axis and compared with the normal pubertal standards of Marshall and Tanner. Age at irradiation was at least 2 SD below the mean age of pubertal onset in normal children. There was a significant linear association between age at irradiation and age at onset of puberty. The onset of puberty occurred at an early age in both sexes (mean, 8.51 yr in girls and 9.21 yr in boys plus 0.29 yr for every year of age at irradiation). For example, the estimated age at onset of puberty in a boy irradiated at 2 yr of age would be 9.79 yr, and that for a boy irradiated at 9 yr of age would be 11.82 yr. In the context of GH deficiency, which is usually associated with a delay in the onset of puberty, this is abnormal. At each age of irradiation, the estimated age at the onset of puberty was approximately 0.7 yr earlier in girls than boys. A similar trend was seen for bone age, which was abnormally early at the time of pubertal onset (mean, 7.39 yr in girls and 8.66 yr in boys plus 0.25 yr for every year of age at the time of irradiation). At the doses of irradiation employed in the treatment of brain tumors, radiation-induced early puberty is not restricted to girls. The clinical consequence of early puberty in the management of poor growth associated with radiation-induced GH deficiency is to foreshorten the time available for treatment with GH.
This article has been cited by other articles:
![]() |
G. T. Armstrong, C. A. Sklar, M. M. Hudson, and L. L. Robison Long-Term Health Status Among Survivors of Childhood Cancer: Does Sex Matter? J. Clin. Oncol., October 1, 2007; 25(28): 4477 - 4489. [Abstract] [Full Text] [PDF] |
||||
![]() |
H K Gleeson and S M Shalet The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours Endocr. Relat. Cancer, December 1, 2004; 11(4): 589 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Gleeson, R. Stoeter, A. L. Ogilvy-Stuart, H. R. Gattamaneni, B. M. Brennan, and S. M. Shalet Improvements in Final Height Over 25 Years in Growth Hormone (GH)-Deficient Childhood Survivors of Brain Tumors Receiving GH Replacement J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3682 - 3689. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Aziz Cancer Survivorship Research: Challenge and Opportunity J. Nutr., November 1, 2002; 132(11): 3494S - 3503. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Taha, W. Bastian, and S. Castells Growth Hormone Replacement Therapy in Children with Leukemia in Remission Clinical Pediatrics, August 1, 2001; 40(8): 441 - 445. [Abstract] [PDF] |
||||
![]() |
M. Schmiegelow, S. Lassen, H. S. Poulsen, K. Schmiegelow, H. Hertz, A.-M. Andersson, N. E. Skakkebak, and J. Muller Gonadal Status in Male Survivors following Childhood Brain Tumors J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2446 - 2452. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kohn, J. R. Julius, and S. L. Blethen Combined Use of Growth Hormone and Gonadotropin-releasing Hormone Analogues: The National Cooperative Growth Study Experience Pediatrics, October 1, 1999; 104(4): 1014 - 1018. [Abstract] [Full Text] |
||||
![]() |
C. L. Clarson and R. F. Del Maestro Growth Failure After Treatment of Pediatric Brain Tumors Pediatrics, March 1, 1999; 103(3): 37e - 37. [Abstract] [Full Text] |
||||
![]() |
C. L. Schwartz Long-Term Survivors of Childhood Cancer: The Late Effects of Therapy Oncologist, February 1, 1999; 4(1): 45 - 54. [Abstract] [Full Text] |
||||
![]() |
J.-P. Bourguignon, J. Jaeken, A. Gerard, and F. de Zegher Amino Acid Neurotransmission and Initiation of Puberty: Evidence from Nonketotic Hyperglycinemia in a Female Infant and Gonadotropin-Releasing Hormone Secretion by Rat Hypothalamic Explants J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1899 - 1903. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Adan, J. C. Souberbielle, J. M. Zucker, A. Pierre-Kahn, C. Kalifa, and R. Brauner Adult Height in 24 Patients Treated for Growth Hormone Deficiency and Early Puberty J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 229 - 233. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |